Hepatitis Market Research Reports & Industry Analysis
Hepatitis Industry Research & Market Reports
-
North America Hepatitis B Treatment Market - 2025-2033
... B is a viral infection that causes inflammation of the liver, which may initially present as mild but, in some cases, can develop into a chronic condition that persists over time. If left untreated, the ... Read More
-
Liver Disease Treatments: The Global Market
... frequently used products, clinical trials, new product approvals, and emerging technologies are also included. The demographics of the major regions—North America, Europe, Asia-Pacific, South America, and the Middle East and Africa—as well as their prospects ... Read More
-
Global Hepatitis B Treatment Market - 2024-2033
... B is a viral infection that causes inflammation of the liver, which may initially present as mild but, in some cases, can develop into a chronic condition that persists over time. If left untreated, the ... Read More
-
Viral Hepatitis and Retrovirus Diagnostic Tests
... reach US$7.7 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 11.3% CAGR The Viral ... Read More
-
Hepatitis Therapeutics
... CAGR of 3.7% over the analysis period 2024-2030. Hepatitis C, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$17.8 Billion by the end of the analysis ... Read More
-
Hepatitis Test Solution/Diagnosis
... at a CAGR of 6.0% over the analysis period 2024-2030. ELISA, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.4 Billion by the end of the ... Read More
-
Hepatitis C Treatment
... at a CAGR of 10.7% over the analysis period 2024-2030. HCV Protease Inhibitors, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$25.3 Billion by the end ... Read More
-
Hepatitis B Vaccines
... at a CAGR of 4.4% over the analysis period 2024-2030. Combination Vaccines, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.6 Billion by the end of ... Read More
-
Alcoholic Hepatitis Treatment
... at a CAGR of 4.3% over the analysis period 2024-2030. Corticosteroids, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$1.7 Billion by the end of the ... Read More
-
2025 Global Forecast for Hepatitis B Treatment Market (2026-2031 Outlook)-High Tech Outlook Report
... or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2026 ... Read More
-
Infectious Disease Molecular Diagnostics Market Size, Share, and Outlook, 2025 Report- By Product & Service (Reagents, Kits, Consumables, Instruments, Software & Services), By Type of Testing (Laboratory Testing, PoC Testing), By Technology (Immunodiagnostics, Polymerase Chain Reaction, Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-generation Sequencing, DNA Microarray, Others), By Disease Type (Hepatitis, HIV, Hospital-acquired Infections, Mosquito-borne Diseases, HPV, Chlamydia trachomatis, Neisseria gonorrhea, Tuberculosis, Influenza, Syphilis, Others), By Sample Type (Blood, Serum, and Plasma, Urine, Others), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, Others), 2021-2032
... business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain. The comprehensive market research report presents 12-year historic and forecast data on Infectious Disease Molecular Diagnostics ... Read More
-
Hepatitis B Virus (HBV) Global Market Report 2025
... virus (hbv) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Hepatitis Vaccine Market Size, Industry Share and Global Forecast 2025 - 2033
... to 2033. The global hepatitis vaccine market is a rapidly growing sector driven by the increasing global burden of hepatitis infections, rising awareness of the importance of vaccination, and advancements in vaccine development. Hepatitis is ... Read More
-
Hepatitis B Vaccine Market Size, Industry Share and Global Forecast 2025 - 2033
... 2025 to 2033. The global Hepatitis B vaccine market plays a pivotal role in controlling and preventing Hepatitis B virus (HBV) infections, which continue to pose significant public health challenges worldwide. Hepatitis B is a ... Read More
-
Hepatitis Therapeutics Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Middle East & Africa Human Vaccine Market Research Report Information by Vaccine Type (Inactivated, Toxoid, Conjugate and Subunit, Recombinant DNA), by Age Group (Pediatrics, and Adults), by Indication (Pneumococcal, Influenza, Hepatitis, DTP, Polio and others), by Administration (Injectable, Oral, and others), by Distribution Channel (Public, and Private) Industry Forecast to 2032
... million by the conclusion of the forecast period (2024-2032), with an estimated value of USD 596.39 million in 2023. The world's sports fields and landscapes have been transformed by the remarkable innovation of artificial grass, ... Read More
-
Antiviral Drugs Market, By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, and Others), By Type (Branded and Generics), By Application (HIV, Hepatitis, Herpes, Influenza, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... been witnessing steady growth over the past few years. Antiviral drugs, also known as antiviral agents or anti-infective medications, are a class of medication used specifically for treating infections caused by viruses. They work by ... Read More
-
Vaccines Market, By Type (Monovalent Vaccines , Multitvalent Vaccines), By Technology (Conjugate Vaccines, Recombinant Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Other Vaccine Technologies), By Disease Indication (Pneumococcal Disease, Influenza, Combination Vaccines, HPV, Meningococcal Disease, Herpes Zoster, Rotavirus, MMR, Varicella, Hepatitis, DTP, Polio, RSV, Other Disease Indications), By Route of Administration (Intramuscular, Subcutaneous, Oral, Intranasal), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... specific diseases and allow populations at risk to be protected from the life-threatening effects of dangerous infections. Growing awareness about immunization, especially in developing nations is propelling the demand for advanced and affordable vaccines globally. ... Read More
-
Global Hepatitis A Vaccine Market - 2022-2029
... hepatitis A is on the rise. Asia-Pacific held a dominant position in the global Hepatitis A Vaccine market in 2021. The competitive rivalry intensifies with GlaxoSmithKline, Zhejiang Pukang, KM Biologics and others operating in the ... Read More
-
Middle East & Africa Human Vaccine Market Research Report Information by Vaccine Type (Inactivated, Toxoid, Conjugate and Subunit, Recombinant DNA), by Age Group (Pediatrics, and Adults), by Indication (Pneumococcal, Influenza, Hepatitis, DTP, Polio and others), by Route of Administration (Injectable, Oral, and others), by Distribution Channel (Public, and Private) Industry Forecast to 2032
... a specific illness, thereby protecting people from infection and its potentially serious effects. These vaccines often contain weakened or dead organisms (such as viruses or bacteria), toxins, or surface proteins that elicit an immune response ... Read More
-
Point-Of-Care Molecular Diagnostics Global Market Report 2025 Including: 1) By Product And Service: Assays And Kits; Instruments And Analyzers; Software And Services 2) By Technology: Reverse Transcription - Polymerase Chain Reaction (RT-PCR); In Situ Hybridization; Sequencing 3) By Application: Respiratory Diseases; Hospital Acquired Infections (HAIs); Cancer/Oncology; Hepatitis; Hematology 4) By End-User: Decentralized Labs; Hospitals; Home Care; Assisted Living Healthcare Facilities Covering: Abbott Laboratories; F Hoffmann-La Roche Ltd.; BioMérieux SA; Danaher Corporation; Quidel Corporation
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Hepatitis Diagnostic Tests Market Report by Test Type (Blood Tests, Imaging Test, Liver Biopsy), and Region 2025-2033
... 2025-2033. The market is experiencing robust growth, driven by the rising prevalence of hepatitis across the globe, rapid technological advancements in diagnostics, increasing public awareness and screening initiatives, implementation of supportive government policies and funding, ... Read More
-
Global Hepatitis B Vaccines Competitive Landscape Professional Research Report 2025
... The vaccines work by stimulating the immune system to produce antibodies that provide immunity to the virus. Hepatitis B is commonly transmitted through contact with infected blood, unprotected sexual activity, or from an infected mother ... Read More
-
Travel Vaccines Market Report by Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and Region 2025-2033
... vaccines market size reached USD 4.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 10.0 Billion by 2033, exhibiting a growth rate (CAGR) of 9.36% during 2025-2033. The market is ... Read More
-
Global Hepatitis B Vaccines Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
... million in 2024 and is forecast to a readjusted size of USD 2025 million by 2031 with a CAGR of 6.3% during review period. Hepatitis B vaccine is a vaccine that prevents hepatitis B. The ... Read More
Research Assistance
